Rhythm Pharmaceuticals
Healthcare & Life Sci
Company overview
Rhythm Pharmaceuticals is a global biopharmaceutical company that develops treatments for rare neuroendocrine diseases. Its main product is IMCIVREE (setmelanotide), an injectable medicine that treats hyperphagia and obesity in patients with rare genetic conditions such as Bardet-Biedl syndrome. The company was founded in Boston in 2008 and is headquartered there. It is a publicly traded company. Rhythm Pharmaceuticals is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- United States